Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
The New England Journal of Medicine
|
May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
, Cora E Lewis, Lawrence J Fine, et al.
JAMA
|
May 29, 2014
Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial
Marco Pahor, Jack M Guralnik, Walter T Ambrosius, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 27, 2017
Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus
Barry I Freedman, Kaycee M Sink, Christina E Hugenschmidt, et al.
Journal of the American Geriatrics Society
|
November 26, 2021
Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study
Sarah A Gaussoin, Nicholas M Pajewski, Gordon Chelune, et al.
JAMA Neurology
|
September 19, 2022
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials
Susanne Ostrowitzki, Tobias Bittner, Kaycee M Sink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 14, 2022
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial
Eric M Reiman, Jeremy J Pruzin, Silvia Rios-Romenets, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 1, 2022
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial
Clara Vila-Castelar, Pierre N Tariot, Kaycee M Sink, et al.
JAMA
|
May 20, 2016
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial
Jeff D Williamson, Mark A Supiano, William B Applegate, et al.
Kidney International
|
June 26, 2016
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume
Barry I Freedman, Crystal A Gadegbeku, R Nick Bryan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)
Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
The New England Journal of Medicine
|
May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
, Cora E Lewis, Lawrence J Fine, et al.
JAMA
|
May 29, 2014
Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial
Marco Pahor, Jack M Guralnik, Walter T Ambrosius, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 27, 2017
Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus
Barry I Freedman, Kaycee M Sink, Christina E Hugenschmidt, et al.
Journal of the American Geriatrics Society
|
November 26, 2021
Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study
Sarah A Gaussoin, Nicholas M Pajewski, Gordon Chelune, et al.
JAMA Neurology
|
September 19, 2022
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials
Susanne Ostrowitzki, Tobias Bittner, Kaycee M Sink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 14, 2022
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial
Eric M Reiman, Jeremy J Pruzin, Silvia Rios-Romenets, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 1, 2022
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial
Clara Vila-Castelar, Pierre N Tariot, Kaycee M Sink, et al.
JAMA
|
May 20, 2016
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial
Jeff D Williamson, Mark A Supiano, William B Applegate, et al.
Kidney International
|
June 26, 2016
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume
Barry I Freedman, Crystal A Gadegbeku, R Nick Bryan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)
Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.
Page
of 8